Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
|
|
G1 Therapeutics, Inc. (GTHX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/24/2023 |
3
| Thomas Monica R. (General Counsel) has filed a Form 3 on G1 Therapeutics, Inc. |
| 03/17/2023 |
3
| Umstead John V. (CFO) has filed a Form 3 on G1 Therapeutics, Inc. |
| 08/02/2022 |
3
| Sharpless Norman (Director) has filed a Form 3 on G1 Therapeutics, Inc. |
| 06/29/2022 |
3
| Lee Jacks (Director) has filed a Form 3 on G1 Therapeutics, Inc. |
| 08/17/2021 |
3
| Perry Andrew (Chief Commercial Officer) has filed a Form 3 on G1 Therapeutics, Inc. |
| 06/21/2021 |
3
| Secor Alicia (Director) has filed a Form 3 on G1 Therapeutics, Inc. |
| 04/01/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/13/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/30/2019 |
3
| Avagliano Mark (Chief Business Officer) has filed a Form 3 on G1 Therapeutics, Inc. |
| 09/13/2018 |
3
| Nicholson Garry A (Director) has filed a Form 3 on G1 Therapeutics, Inc. |
| 07/06/2018 |
3
| DEMAREE JOHN (Chief Commercial Officer) has filed a Form 3 on G1 Therapeutics, Inc. |
| 06/27/2018 |
3
| Hanson James S. (General Counsel) has filed a Form 3 on G1 Therapeutics, Inc. |
| 06/11/2018 |
3
| Schwalm Cynthia (Director) has filed a Form 3 on G1 Therapeutics, Inc. |
| 06/11/2018 |
3
| Deese Willie A (Director) has filed a Form 3 on G1 Therapeutics, Inc. |
| 11/15/2017 |
3
| PHILLIPS BARCLAY A (SVP & CFO) has filed a Form 3 on G1 Therapeutics, Inc. |
| 08/03/2017 |
3
| MURDOCK TERRY L (SVP of Development Operations) has filed a Form 3 on G1 Therapeutics, Inc. |
| 07/13/2017 |
3
| WITTY ANDREW (Director) has filed a Form 3 on G1 Therapeutics, Inc. |
| 05/19/2017 |
3
| Sullivan Timothy Eugene (Director) has filed a Form 3 on G1 Therapeutics, Inc. |
| 05/17/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 05/17/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 05/17/2017 |
3
| Thorp Clay (10% Owner) has filed a Form 3 on G1 Therapeutics, Inc. |
| 05/16/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 05/16/2017 |
3
| RUDNICK SETH (Director) has filed a Form 3 on G1 Therapeutics, Inc. |
| 05/16/2017 |
3
| Rivers Tyrell (Director) has filed a Form 3 on G1 Therapeutics, Inc. |
| 05/16/2017 |
3
| MUIR GLENN P (Director) has filed a Form 3 on G1 Therapeutics, Inc. |
| 05/16/2017 |
3
| Strum Jay (Chief Scientific Officer) has filed a Form 3 on G1 Therapeutics, Inc. |
| 05/16/2017 |
3
| MOSSINGHOFF GREGORY J (Chief Business Officer) has filed a Form 3 on G1 Therapeutics, Inc. |
| 05/16/2017 |
3
| Moses Jennifer K. (VP of Finance & Admin) has filed a Form 3 on G1 Therapeutics, Inc. |
| 05/16/2017 |
3
| Malik Rajesh (Chief Medical Officer) has filed a Form 3 on G1 Therapeutics, Inc. |
| 05/16/2017 |
3
| Malik Rajesh (Chief Medical Officer) has filed a Form 3 on G1 Therapeutics, Inc. |
| 05/16/2017 |
3
| Velleca Mark A. (President and CEO) has filed a Form 3 on G1 Therapeutics, Inc. |
| 05/16/2017 |
3
| RA CAPITAL MANAGEMENT, LLC (10% Owner) has filed a Form 3 on G1 Therapeutics, Inc. |
|
|